Ariad Pharmaceuticals (ARIA) gains on Sarissa deal, CEO quits

Ariad Pharmaceuticals, Inc.

gained 2.7% to $9.11 after the company reported a settlement deal with Sarissa Capital Management and announced the retirement of founder and Chairman, CEO Harvey Berger. Share volume was 720,000, compared to an all-day average of 6.1 million